Ebola vaccine troubles; scientists question brain-training; conversation with a stem cell pioneer
ISTOCK, MARK GILLOW
On his blog, the University of California, Davis’s Paul Knoepfler spoke about the clinical use of induced pluripotent stem cells with field pioneer and Nobel Laureate Shinya Yamanaka. “Stem cells provide unprecedented opportunities in stem cell therapy and drug development,” Yamanaka told Knoepfler. (Read about stem cell therapies for blindness in this month’s BioBusiness story, “Eyes on the Prize.”)
Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.
View this Issue
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating technology options for their laboratories.
Discover how to examine and alter histone modification mechanisms to explore the role of epigenetics in health and disease.
Discover how genetic and epigenetic analysis helps identify early disease biomarkers.
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Singleron Biotechnologies and Hamilton Bonaduz AG today announced the official launch of Tensor under their strategic partnership.
Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overallunderstanding of RNA.
New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and Beyond
